Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Heart Attack Clinical Trials
Heart Attack clinical trials are recruiting across 210 cities. Here are the cities with the most active studies:
Heart Attack Trial Phases
83 research organizations are sponsoring heart attack trials.
About Heart Attack
A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.
Clinical trials are advancing new treatments for heart attack. Currently, 100 studies are recruiting a combined 724,497 participants across the United States. Research is being conducted by 83 organizations including ClinLogic LLC, Mayo Clinic, University of Massachusetts, Worcester and 80 others.
2026 Heart Attack Research Landscape
As of July 2026, the heart attack clinical trial landscape includes 100 actively recruiting studies across 210 cities in the United States. These studies are collectively seeking 724,497 participants, with an average enrollment target of 7,245 per study.
The research spans multiple phases of development: 15 studies are in NA, 12 studies are in PHASE3, 4 studies are in PHASE2, 4 studies are in PHASE4, 2 studies are in PHASE1. The presence of Phase 3 trials indicates that some heart attack treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 83 different organizations, including ClinLogic LLC, Mayo Clinic, University of Massachusetts, Worcester, Medtronic, Children's National Research Institute, and 78 others. The large number of sponsors reflects significant research interest and investment in heart attack treatment advancement.
Geographically, heart attack trials are most concentrated in Los Angeles, California (21 trials); Phoenix, Arizona (16 trials); Washington D.C., District of Columbia (13 trials); Baltimore, Maryland (11 trials); Chicago, Illinois (11 trials) and 7 other cities.
Featured Heart Attack Studies
Highlighted recruiting studies for heart attack, selected by enrollment size and research scope.
Reduction of Adverse Drug Events and Readmissions
Pharmocogenomic test assessment in the medication regimen and disease management for patients under drugs known with genetic variation.
The REgistry of Very Early Estrogen and AnovuLation
The purpose of this study is to to build a registry of women with early estrogen loss due to Functional Hypothalamic Amenorrhea (FHA) to understand the prevalence, racial and ethnic diversity of this condition.
Social Needs Screening and Chronic Diseases Study (WE CARE)
The goal of this clinical trial is to learn if the implementation of the WE CARE social determinants of health (SDOH) screening and referral intervention with an antiracist lens in primary care settings can lead to a meaningful decrease in chronic disease by monitoring conditions such as hypertension, diabetes, depression, hyperlipidemia, and asthma through clinical measures. The main question it ...
Frequently Asked Questions About Heart Attack Clinical Trials
Are there heart attack clinical trials near me?
Yes, there are 100 heart attack clinical trials currently recruiting across 210+ cities in the United States, including Los Angeles, California; Phoenix, Arizona; Washington D.C., District of Columbia. Browse the studies above to find one at a location convenient for you.
How do I join a heart attack clinical trial?
To join a heart attack clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are heart attack clinical trials free?
Yes, participation in heart attack clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of heart attack treatments are being studied?
Current heart attack clinical trials are testing a range of approaches across NA (15 studies), PHASE3 (12 studies), PHASE2 (4 studies), PHASE4 (4 studies), PHASE1 (2 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 83 research organizations.
Is it safe to participate in heart attack clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov